On analyzing data from The Cancer Genome Atlas (TCGA), we found expression levels of IRF9 (Figure 1c), STAT1, and STAT2 in patients with lung cancer (Figure 1d), and IRF9 expression levels were positively correlated with those of STAT1 and STAT2 (Figure 1e). This evidence concerns the gene STAT2 and lung cancer.